Ikoma, Japan

Hisashi Tajima


 

Average Co-Inventor Count = 6.6

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2009-2013

Loading Chart...
Loading Chart...
11 patents (USPTO):

Title: The Innovative Contributions of Hisashi Tajima

Introduction

Hisashi Tajima is a prominent inventor hailing from Ikoma, Japan. With an impressive portfolio of 11 patents, he has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diseases linked to angiogenesis and vascular permeability.

Latest Patents

Hisashi Tajima's latest innovations include two noteworthy patents. The first is a compound featuring a 4-pyridylalkylthio group as a substituent, which is formulated to treat diseases where angiogenesis or increased vascular permeability is a factor. This compound includes various functional groups such as aromatic five-membered heterocycles and various substitutions including hydrogen, hydroxyl, and alkyl groups.

The second recent patent concerns a cyclic compound with a pyrimidinylalkylthio group. This patent details a method for treating diseases associated with angiogenesis by using a therapeutically effective amount of this compound or its salt. The intricate design of these compounds suggests a deep expertise in medicinal chemistry and a commitment to developing novel therapies.

Career Highlights

Hisashi Tajima is currently affiliated with Santen Pharmaceutical Co., Ltd., a company renowned for its dedication to ophthalmology and pharmaceuticals. His work has significantly impacted the development of therapeutic agents aimed at addressing complex medical conditions. His extensive research and innovations have established him as a leading figure in his field.

Collaborations

In his professional journey, Tajima has collaborated with esteemed colleagues such as Minoru Yamamoto and Takahiro Honda. Working alongside other skilled researchers has allowed him to share insights and leverage diverse expertise, fostering a collaborative environment that drives innovation.

Conclusion

Hisashi Tajima's contributions to the pharmaceutical industry exemplify the spirit of innovation and dedication to improving health outcomes. With a solid track record of patents and collaborative efforts, he continues to be a valuable asset in the realm of medical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…